William C Bertrand Jr's Net Worth

$7.01 Million

Estimate Recalculated Nov 11, 2024 08:01AM EST

Who is William C Bertrand Jr?

William C Bertrand Jr has an estimated net worth of $7.01 Million. This is based on reported shares across multiple companies, which include Adaptimmune Therapeutics PLC, ARDELYX, INC., INFINITY PHARMACEUTICALS, INC., SANTARUS INC, SALIX PHARMACEUTICALS LTD, and MEDIMMUNE INC /DE.

SEC CIK

William C Bertrand Jr's CIK is 0001291937

Past Insider Trading and Trends

2020 was William C Bertrand Jr's most active year for acquiring shares with 6 total transactions. William C Bertrand Jr's most active month to acquire stocks was the month of May. 2007 was William C Bertrand Jr's most active year for disposing of shares, totalling 10 transactions. William C Bertrand Jr's most active month to dispose stocks was the month of December. 2020 saw William C Bertrand Jr paying a total of $250,079.10 for 1,791,663 shares, this is the most they've acquired in one year. In 2015 William C Bertrand Jr cashed out on 31,258 shares for a total of $5,407,634.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Adaptimmune Therapeutics PLC (ADAP) Snapshot price: $1.09

Chief Operating Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-40.26%
-23.59K
$0.71
-$16,423.08
35.01K
Jan 16 - Jan 17
Form 4
—
0
—
—
0
Jan 15
Form 4
-39.77%
-9.23K
$0.85
-$7,812.73
13.98K
Jan 11 - Jan 12
Form 4
-37.94%
-4.44K
$1.86
-$8,249.52
7.26K
Jan 17
Form 4
—
0
—
—
0
Jan 17
Form 4
-37.99%
-8.82K
$1.73
-$15,196.89
14.39K
Jan 11 - Jan 12
Form 4
-38.27%
-3.58K
$1.69
-$6,071.30
5.78K
Jan 4
Form 4
-37.32%
-4.37K
$3.19
-$13,941.78
7.34K
Jan 18
Form 4
-37.34%
-6.02K
$3.55
-$21,375.90
10.1K
Jan 11 - Jan 12
Form 4
—
0
—
—
0
Jan 12
Form 4
-37.27%
-3.49K
$4.06
-$14,184.06
5.87K
Jan 4
Form 4
-37.38%
-4.38K
$4.26
-$18,658.94
7.33K
Jul 2
Form 4
-37.22%
-2.23K
$6.15
-$13,744.01
3.77K
Jan 12
Form 4
—
0
—
—
0
Jan 11
Form 4
-37.37%
-3.50K
$5.33
-$18,642.32
5.86K
Jan 4
Form 4
+266.04%
207K
$0.69
$143,823.60
284.81K
Dec 14
Form 4
—
0
—
—
0
Jan 16
Form 4
-39.94%
-2.40K
$5.13
-$12,307.88
3.6K
Jan 14
Form 4
-39.85%
-3.73K
$1.20
-$4,477.20
5.63K
Jan 6
Form 4
-37.84%
-2.27K
$5.37
-$12,193.91
3.73K
Jan 14
Form 4
—
0
—
—
0
Jan 4
Form 4
—
0
—
—
0
Jan 12
Form 3
—
0
—
—
0
No matching records found

ARDELYX, INC. (ARDX) Snapshot price: $5.61

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+5.04%
11.02K
—
—
229.77K
Jun 14
Form 4
+8.20%
16.58K
—
—
218.74K
Jun 15
Form 4
+141.97%
118.61K
—
—
202.16K
Jun 15
Form 4
+11.91%
8.89K
—
—
83.55K
Jun 16
Form 4
+25.14%
15K
$7.08
$106,255.50
74.66K
Dec 14
Form 4
+14.43%
7.52K
—
—
59.66K
Jun 9
Form 4
+53.85%
18.25K
—
—
52.13K
Jun 13
Form 4
+57.75%
12.41K
—
—
33.89K
Jun 13
Form 4
+117.99%
11.63K
—
—
21.48K
Jun 7
Form 4
+97.08%
4.85K
—
—
9.85K
Jun 2
Form 4
∞
5K
$20.00
$100,000.00
5K
Dec 17
Form 4
—
0
—
—
0
Oct 26
Form 3
—
0
—
—
0
No matching records found

INFINITY PHARMACEUTICALS, INC. (INFIQ) Snapshot price: $0.000001

General Counsel

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Oct 19
Form 3
—
0
—
—
0
No matching records found

SANTARUS INC No price found

Secretary

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found

SALIX PHARMACEUTICALS LTD No price found

See Remarks

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-31.26K
$173.00
-$5,407,634.00
0
Apr 1
Form 4
+10.04%
2.85K
—
—
31.26K
Jan 31
Form 3
—
0
—
—
0
Form 4
∞
14.43K
—
—
14.43K
Jul 24
Form 3
—
0
—
—
0
No matching records found